Branford Castle Buys Floratine, First Platform Deal for Fund III

Branford Castle Partners has acquired Floratine Products Group, a Collierville, Tennessee-based maker of specialty plant-nutrition products, in the first platform investment for its third fund. The parties did not disclose the purchase price.

The deal gives Branford Castle, a lower-middle-market private equity firm with more than 40 years of investing history, a foundation in specialty plant nutrition. Floratine, founded in 1991, develops foliar, soil and specialty nutrition products aimed at improving turf health, appearance and stress tolerance. Its customers — golf course superintendents, athletic field managers and other turf professionals — buy through an international distributor network backed by in-house diagnostics and technical support.

What does the acquisition include?

Floratine brings more than its core sports turf business. The company also operates Earthstrong, an agricultural subsidiary established in 2021 that applies Floratine's science-based nutrition capabilities to crop production, with a focus on soil health and crop performance. Earthstrong gives Branford Castle a growth vector beyond golf courses and athletic fields.

Branford Castle is partnering with Floratine President and CEO Kevin Cavanaugh, Mike Cavanaugh and the broader management team. The stated playbook: continued product innovation, deeper distributor relationships, expanded product offerings and disciplined growth across sports turf and agriculture.

The transaction also lets the firm leverage its strategic relationship with Marubeni Corporation, which John S. Castle, President and CEO of Branford Castle Partners, expects could enhance value. "Floratine is an excellent first investment for Fund III and reflects our continued focus on building niche market leaders," Castle said.

How does the deal fit the firm's strategy?

Branford Castle typically pursues controlling investments in companies generating up to $15 million in EBITDA, across industrials and specialty manufacturing, consumer products, business services and logistics. The Floratine purchase matches its pattern of buying established niche-market leaders with differentiated products, long-standing customer relationships and experienced management teams.

Ceon Francis, Managing Director at Branford Castle Partners, was blunt about the fit. "Floratine fits our investment criteria to a tee: a leader in a specialized market, differentiated products, long-standing customer relationships and an experienced management team," Francis said, adding that the company is "uniquely positioned to capitalize on attractive sector trends across sports and agriculture."

Kevin Cavanaugh framed the sale as acceleration rather than exit. "Branford Castle shares our commitment to building on our industry-leading market presence, and we are thrilled to be partnering with them as we accelerate our long-term growth strategy," he said, pointing to plans for continued innovation and expanded distribution.

Who financed and advised the deal?

The advisory and financing roster is standard mid-market structure:

• Akerman — transaction legal counsel to Branford Castle
• Vedder — financing legal counsel
• RSM — accounting and tax advisory
• Bridgepoint Investment Banking — financial advisor to Floratine
• Byline Bank — senior debt financing
• Northstar Capital — mezzanine debt financing

What is not said?

No revenue, EBITDA or valuation figures were disclosed, so Floratine's actual size within Branford Castle's stated deal range — up to $15 million in EBITDA — cannot be verified. The Marubeni relationship is described as an "opportunity" and an expectation, not a committed plan; no concrete commercial arrangements between the Japanese trading house and Floratine were announced.

The test ahead is execution: whether product innovation and distributor deepening can convert a 34-year-old turf nutrition franchise into a broader agricultural platform under Fund III's ownership.